NCT04845152

Brief Summary

The investigators propose here by the use of the French version of the migraine disease screening questionnaire (ID Migraine ™) to study the prevalence of migraine disease in a population of electrohypersensitive patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
317

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 14, 2021

Completed
16 days until next milestone

Study Start

First participant enrolled

April 30, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2022

Completed
Last Updated

June 26, 2023

Status Verified

June 1, 2023

Enrollment Period

7 months

First QC Date

April 10, 2021

Last Update Submit

June 23, 2023

Conditions

HeadacheMigraine

Keywords

Electrohypersensitivity

Outcome Measures

Primary Outcomes (1)

  • Possible migraine attack

    With the number of positive response to the French version of the migraine disease screening questionnaire, we are looking for the patients declaring themselves electrohypersensitive if they have had headaches in the last 12 months with characteristics that could evoke a migraine attack.

    12 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

An adult declaring himself electrohypersensitive

You may qualify if:

  • Informed Consent
  • years or older at the time of informed consent
  • With all these criteria :
  • the perception by the subjects of various non-specific functional symptoms
  • the absence of clinical and biological evidence to explain the symptoms
  • the attribution by the subjects themselves of these symptoms to exposure to electromagnetic fields, which are themselves diverse
  • the symptoms are chronic (more than 3 months)
  • the symptoms appear during an exposure to a source of electromagnetic radiation and cease after the exposure is stopped
  • the symptoms are reproducible

You may not qualify if:

  • \- age under 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

HeadacheMigraine Disorders

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Frédéric GRECO

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2021

First Posted

April 14, 2021

Study Start

April 30, 2021

Primary Completion

December 1, 2021

Study Completion

January 30, 2022

Last Updated

June 26, 2023

Record last verified: 2023-06

Locations

FR(1)